Dyadic International, Inc. (OTC Pink: DYAI) is a global biotechnology company located in Jupiter, Florida with its main research and development operations located in The Netherlands. Dyadic is focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries.
Heartland Global is a farm, agribusiness investment, and economic development business focused on emerging markets, ag-innovation and advisory services. We deliver food and livestock value-chain innovations that provide lasting economic and livelihood growth, helping farmers, agribusiness, and communities solve their own needs sustainably. Agribusiness investment and support ● Emerging market growth ● Business-to-Business and Public-Private partnerships ● Innovation and Technology transfer ● Business and Market development/evaluation.
Advanced Plasma Solutions (APS) specializes in providing products and solutions using Non-Thermal Plasma (NTP) technology for commercial as well as consumer use in the fields of Energy, Environmental Control, Agriculture, and Medicine. We work closely with our customers and partners to convert Non-Thermal Plasma technology applications into commercial realities.We are excited to be part of the innovative development of NTP technology and its multitude of applications that will help make our world a better place. NTP applications are effective and applied in: Air sterilization Water…
Cadence is a communications, research and consulting firm focused on supporting our clients through greater awareness, knowledge and understanding of their markets. We offer services in three critical areas: market research, consulting and medical communications. Our innovative approach to project work leverage our capabilities across all three practice areas to drive efficiencies and deeper insights for all our clients.
HemoGenyx LLC, a privately held biopharmaceutical company, is developing new methods of hematopoietic system regeneration. Our goal is to eliminate the need for allogeneic bone marrow transplantations from medical practice and drastically improve autologous ones. We propose a new approach that is based on the use of a novel type of hemogenic cells that are 100% patient-matched and have not undergone the malignant transformations that are responsible for most leukemias and lymphomas.
Pyxant Labs Inc. is a Contract Research Organization (CRO) providing laboratory services support to pharmaceutical companies in their drug development processes. We help pharmaceutical companies develop drugs.
Cubist Pharmaceuticalsis a bio-pharmaceutical company focused on the research, commercialization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.
Lydall, Inc. (NYSE: LDL) designs and manufactures specialty engineered products for thermal/acoustical, filtration/separation, and bio/medical applications.The Performance Materials segment offers filtration media solutions for air, fluid power, industrial, and life science applications; and industrial thermal insulation solutions, such as nonwoven veils, papers, mats, and specialty composites for the building products, appliance, and energy and industrial markets. The Vital Fluids segment offers products for cryogenic storage, blood transfusion and cell therapy applications in the life…
We're the biggest little bank in the biggest little state. What does that mean for our customers? It means our bank operates with a can-do attitude--the very same mindset that drives the individuals, families and businesses that bank with us. Then we add in legendary customer service. Freedom is known in every corner of the Ocean State (and beyond) as always willing to go the extra nautical mile for our customers.And to complement our group of experienced customer service representatives, mortgage experts and commercial banking specialists, we offer the very latest financial products and…
A development stage start-up, Brain Backups is developing technology to image mouse and human brains non-destructively and non-invasively. This work is important to develop therapies and drugs for neurological disease and to understand how the brain changes over time.Brain Backups is actively developing new methods and has developed a number of proprietary techniques for imaging neurons using synthetic biology, MRI, smart contrast agents and sensors, and aptamer-based technology.With the rapidly falling price of computer and hard drive storage, the price of buying the storage necessary to…
TotipotentRX Corporation is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. We operate three distinct businesses to serve patients, physicians and partners: Therapeutics Division Contract Services Division Cell Manufacturing and Banking Division The company has developed 10 autologous 60-90 minute bedside treatments in the areas of cardiology, vascular, and orthopedic medicine. TotipotentRX announced the significant top line results of its Phase Ib (safety and efficacy) trial for no-option critical limb ischemia in…
Vaxess Technologies is a venture-backed life sciences company developing novel heat-stable vaccine formulations based on its proprietary silk stabilization platform. We are committed to improving access to vaccines by enabling truly global products that can be more effectively delivered throughout both the developed and developing world.
Innoveas International is a leading innovation company, transforming world class technologies and innovative scientific ideas from universities and public research Institutions in Germany into game-changing enterprises. The company invests in high impact innovations in the global healthcare, energy, digital and environmental sectors.
Lipella Pharmaceuticals Inc. is a privately held development-stage biotechnology company dedicated to improve patient care by developing novel products which focus on trans-mucosal therapy, delivering local treatments directly to their site of action. Lipella focuses on four therapeutic areas: urology, otorhinolaryngology, gastroenterology, and dermatology. In each of these areas, Lipella has liposomal therapies in various stages of development ranging from pre-clinical to early clinical in the U.S. and overseas.
OverviewFibeRio Technology Corp. ("FibeRio" or the "Company") has developed revolutionary Forcespinning™ technology to produce nanofibers at commercial scale. This Forcespinning approach has the potential to replace 50+ year old electrospinning technology which is an order of magnitude less productive, over 4x more expensive, limiting in terms of materials and volume capabilities, and results in hazardous waste and disposal issues. The market and applications for nanofibers is expected to grow dramatically over the next 10 years across almost every industry (filtration, energy, textiles,…
U-M Tech Transfer is the University organization responsible for the transfer of University technology to the marketplace.Mission:To effectively transfer University technologies to the market so as to generate benefits for the University, the community and the general public.
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.Our first commercial product is Soliris® (eculizumab), the world's first and only approved terminal complement inhibitor. Today, Soliris is approved in…
Sequenom, Inc.Sequenom, Inc. (NASDAQ: SQNM) designs, develops, manufactures and markets innovative technology, instrumentation and tests that target and serve discovery and clinical research, and clinical molecular diagnostics markets. Applications include translational research, oncology, agricultural genomics and in vitro diagnostics for prenatal and retinal disorders.Technologies employed include mass spectrometry and second generation DNA sequencing. The company's proprietary MassARRAY system is a high-performance mass spectrometry based DNA analysis platform that efficiently and…